. 2020 Nov 9;10(4):214. doi: 10.3390/jpm10040214

Table 1.

Summary of drug usage, dietary supplements, and comorbidities for patients with mental illness ^a.

	Total		Non-Disease		Disease (=Yes)		Depression (=Yes)		Anxiety (=Yes)		Schizophrenia (=Yes)
Variables	$n$	$%$	$n$	$%$	$n$	$%$	$n$	$%$	$n$	$%$	$n$	$%$
Total	68,209	100.0	45,968	67.39	22,241	32.61	10,080	14.72	15,229	22.24	258	0.38
Gender ^b
Male	37,959	44.35	23,552	51.26	6698	30.12	2912	28.89	4445	29.19	150	58.14
Female	30,250	55.65	22,416	48.76	15,543	69.88	7168	71.11	10,784	70.81	108	41.86
Age (Years)
0–10	487	0.71	237	0.52	250	1.12	25	0.25	229	1.50	0	0.0
11–20	2637	3.87	634	1.38	2003	9.01	858	8.51	1455	9.55	5	1.94
21–30	4641	6.80	1264	2.75	3377	15.18	1312	13.02	2571	16.88	19	7.36
31–40	5647	8.28	2235	4.86	3412	15.34	1402	13.91	2517	16.53	46	17.83
41–50	7727	11.33	4368	9.50	3359	15.10	1521	15.09	2356	15.47	34	13.18
51–60	13,491	19.78	9480	20.62	4011	18.03	1944	19.29	2632	17.28	72	27.91
61–70	14,811	21.71	11,789	25.65	3022	13.59	1556	15.44	1787	11.73	61	23.64
>70	18,768	27.51	15,961	34.72	2807	12.62	1462	14.50	1682	11.04	21	8.14
IDD
No	67,481	98.93	45,365	98.69	22,115	99.43	10,013	99.34	15,157	99.53	253	98.06
Yes	729	1.07	603	1.31	126	0.57	67	0.66	72	0.47	5	1.94
HT
No	48,777	28.49	5718	12.44	13,714	61.66	5847	58.01	9739	63.95	152	58.91
Yes	19,433	71.51	40,250	87.56	8527	38.34	4233	41.99	5490	36.05	106	41.09
OA
No	65,501	96.02	43,933	95.57	21,567	96.97	9714	96.37	14,785	97.08	248	96.12
Yes	2709	3.97	2035	4.43	674	3.03	366	3.63	444	2.92	10	3.88
CM
No	68,016	99.72	45,808	99.65	22,207	99.85	10,063	99.83	15,209	99.87	258	100.0
Yes	194	0.28	160	0.35	34	0.15	17	0.17	20	0.13	0	0.0
Obesity
No	59,601	87.38	39,346	85.59	20,255	91.07	9019	89.47	13,974	91.76	226	87.60
Yes	8609	12.62	6622	14.41	1986	8.93	1061	10.53	1255	8.24	32	12.40
CDH
No	68,153	99.92	45,918	99.89	22,234	99.97	10,076	99.96	15,225	99.97	258	100.0
Yes	57	0.08	50	0.11	7	0.03	4	0.04	4	0.03	0	0.0
HF
No	66,069	96.86	44,189	96.13	21,879	98.37	9876	97.98	15,005	98.53	256	99.22
Yes	2141	3.14	1779	3.87	362	1.63	204	2.02	224	1.47	2	0.78
CVD
No	68,115	99.86	45,899	99.85	22,215	99.88	10,063	99.83	15,216	99.91	257	99.61
Yes	95	0.14	69	0.15	26	0.12	17	0.17	13	0.09	1	0.39
AS
No	68,145	99.90	45,915	99.88	22,229	99.95	10,071	99.91	15,222	99.95	258	100.0
Yes	65	0.10	53	0.12	12	0.05	9	0.09	7	0.05	0	0.0
CAD
No	59,504	87.24	38,433	83.61	21,070	94.73	9455	93.80	14,523	95.36	245	94.96
Yes	8706	12.76	7535	16.39	1171	5.27	625	6.20	706	4.64	13	5.04
ND
No	68,121	99.87	45,901	99.85	22,219	99.90	10,075	99.95	15,213	99.989	256	99.22
Yes	89	0.13	67	0.15	22	0.10	5	0.05	16	0.10	2	0.78
E-CRP
No	67,969	99.65	45,800	99.63	22,168	99.67	10,059	99.79	15,167	99.59	256	99.22
Yes	241	0.35	168	0.37	73	0.33	21	0.21	62	0.41	2	0.78
E-ESR
No	67,900	99.55	45,757	99.54	22,142	99.55	10,039	99.59	15,154	99.51	258	100.0
Yes	310	0.45	211	0.46	99	0.45	41	0.41	75	0.49	0	0.0
LTUA
No	67,911	99.56	45,715	99.45	22,195	99.79	10,058	99.78	15,195	99.78	258	100.0
Yes	299	0.44	253	0.55	46	0.21	22	0.22	34	0.22	0	0.0
BMI^c (mean ± std)	(50.25 ± 1108.60)
Underweight (<18.5)	1323	1.93	616	1.34	707	3.18	225	2.23	563	3.70	3	1.16
Normal (18.5–24.99)	12,535	18.38	7062	15.36	5473	24.61	2142	21.25	4008	26.32	59	22.87
Overweight (25–29.99)	18,757	27.50	12,939	28.14	5817	26.15	2532	25.12	4052	26.61	84	32.56
Obese (30–39.99)	26,075	38.23	18,720	40.72	7532	33.06	3571	35.43	4803	31.54	88	34.11
Severe Obese ( $\geq$ 40)	9523	13.96	6631	14.43	2892	13.00	1610	15.97	1803	11.84	24	9.30
LAB ^d
CRP	595	41.01	382	42.97	213	37.90	87	38.16	170	38.81	0	0.00
ESR	856	58.99	507	57.03	349	62.10	141	61.84	268	61.19	1	100.0
LabValue ^e (mean ± std)	(17.79 ± 28.97)
E_Mycin
No	68,192	99.97	45,958	99.98	22,233	99.96	10,076	99.96	15,223	99.96	258	100.0
Yes	18	0.03	10	0.02	8	0.04	4	0.04	6	0.04	0	0.00
C_Mycin
No	67,636	99.16	45,619	99.24	22,016	98.99	9988	99.09	15,066	98.93	257	99.61
Yes	574	0.84	349	0.78	225	1.01	92	0.91	163	1.07	1	0.39
Z_pak
No	48,024	70.41	33,374	72.60	14,649	65.86	6437	63.86	9969	65.46	201	77.91
Yes	20,186	29.59	12,594	27.40	7592	34.14	3643	36.14	5260	34.54	57	22.09
Folate
No	68,131	99.88	45,921	99.90	22,209	99.86	10,062	99.82	15,209	99.87	257	99.61
Yes	79	0.12	47	0.10	32	0.14	18	0.18	20	0.13	1	0.39
VitB6
No	68,050	99.77	45,862	99.77	22,187	99.76	10,054	99.74	15,194	99.77	258	100.0
Yes	160	0.23	106	0.23	54	0.24	26	0.26	35	0.23	0	0.00
CoQ
No	67,589	99.09	45,490	98.96	22,098	99.36	10,017	99.37	15,137	99.40	258	100.0
Yes	621	0.91	478	1.04	143	0.64	63	0.63	92	0.60	0	0.0
O3FO
No	68,026	99.73	45,823	99.68	22,202	99.82	10,058	99.78	15,202	99.82	257	99.61
Yes	184	0.27	145	0.32	39	0.18	22	0.22	27	0.18	1	0.39

Abbreviations: AS, Atherosclerosis; BMI, Body Mass Index; CAD, Coronary Artery Disease; CDH, CongenitalDiseaseOfHeart; CM, CancerMalignant; CVD, Cardiovascular Disease; C_Mycin, Clarithromycin; CoQ, Coenzyme Q10; E-CRP, Elevated C-reactive Protein; E-ESR, Elevated Erythrocyte Sedimentation Rate; E_Mycin, Erythromycin; HF, HeartFailure; HT, Hypertension; IDD, InsulinDependentDiabetes; LTUA, LongTermUseOfAntibiotics; LV, LabValue; ND, NutritionDeficiency; O3FO, Omega3FishOil; OA, Osteoarthritis; VitB6, Vitamin B-6; Z_pak, Azithromycin; ^a Some variable names are abbreviated to display the complete table; ^b One unidentified gender and missing data values for three patients (0.006%); ^c Body Mass Index (BMI) missing data values for 434 patients $(0.6 %)$ ; ^d LAB missing data values for 67, 195 patients $(97.8 %)$ ; ^e LabValue with miscellaneous values for six patients, $< 0.3$ for 10 patients, $< 0.1$ for three patients, and missing data values for 67, 195 patients $(97.8 %)$ .